‘Ozempic for dogs’ may be the next big thing in pet health

With the illegal success of drugs such as Özempic and Mounjaro, it helps people effectively, researchers and biotechnology firms now set a new limit: weight loss drugs for dogs.

Up to 60 percent of dogs in the UK estimated To be overweight or obese, the market of such drugs may be remarkable.

Okava, a San Francisco-based bio-company-based company, specializing in Pet Health, plans to try to make a drug designed to mimic the effects of Özempic, and the goal of producing an implant version for dogs that last six months at a time.

In accordance with To predictions On the company’s website, the current market for such a product can be worth 10 billion dollars and they hope to have an early dog weight loss of 2028 or 2029.

In human weight loss drugs, the active ingredient in Mounjaro is called tirzepathide and is in Semaglud in Özempic. Both work similarly, imitating a natural hormone called GLP-1.

This hormone regulates blood sugar and appetite, ultimately leads to people feel more full and reduce food intake.

The difficulty for biotechnology firms is to reproduce this effect in dogs, which are practically known for unlimited Goring.

Hope is that a algum -like drug can reduce the beggar behavior of dogs where many owners have difficulty resisting to reward.

Often, lack of appetite in dogs is associated with disease, ie developing an effective drug that makes domestic animals look good. Such a drug called Santrol was released in 2007, but did not sell well because of how the owners perceived their pet behavior when they were in drugs.

Okava’s planned implant, called OKV-119, contains a GLP-1 mimic called enenatide.

Okava’s General Manager Michael Klotsman said that the behavior changes of dogs from OKV-119 will be quite different from the loss of appetite about the disease.

“The owners should expect to see, their pets eat suitable portions without the obsession of food – they will still show interest in food and food, without excessive beggar, cleaning or swallowing behavior,” he said Guardian.

However, not all queues shake. In most cases, veterinarians suggested that dog owners would be better than to avoid obesity in their dogs by exercising more exercise and restricting the diet of their pets.

Caroline Allen, President of RSPCA’s Veterinary Independent: “A healthy diet and exercise is the best way to keep our pets happy and good, but we understand that their owners can sometimes struggle to manage the weight of their pets. Currently, there is little information about weight loss implants or vaccines for animals.

“Before applying for such interventions, the owners should get help to offer many opportunities to exercise and play in a way that they will reduce the weight of their pets from their veterinarians with a good diet.”

“Weight loss jabs or implants may have a role that will play in the future under very limited conditions that animals are not clinically good, but the best thing we can do is to create healthy habits from the beginning so that our pets can live the best possible life.”